Aethlon Medical

Aethlon Medical, Inc. is a medical technology company based in San Diego, California, specializing in the development of innovative immunotherapeutic devices aimed at diagnosing and treating life-threatening diseases. The company's flagship product, the Aethlon Hemopurifier, is a clinical-stage device designed to selectively remove exosomes and dangerous viruses from the human circulatory system. Additionally, Aethlon is working on TauSome, an exosomal biomarker candidate intended for the diagnosis of chronic traumatic encephalopathy in living patients. Aethlon Medical also collaborates with the University of Pittsburgh on research related to head and neck cancer, reflecting its commitment to addressing unmet medical needs in both health and biodefense. Founded in 1999, the company is focused on creating effective therapeutic solutions for patients facing serious health challenges.